Travere Therapeutics Inc (TVTX) — Capital Reinvestment Ratio
Travere Therapeutics Inc (TVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow ($60.68 Million) in capital expenditures ($375.00K). Check how tangible is Travere Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Travere Therapeutics Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks Travere Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Travere Therapeutics Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Travere Therapeutics Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for Travere Therapeutics Inc from 2017 to 2025. See TVTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.54x | $37.78 Million | $58.16 Million | ▼ -18.7% |
| 2017 | 1.89x | $7.40 Million | $14.01 Million | — |